Sponsor & Developer Portfolio
Mark Stegall
Clinical development pipeline, platform architecture, and registered trial tracking for Mark Stegall vaccine candidates.
1
Candidates
1
Target Diseases
1
Linked Studies
Development Phase Distribution
Discontinued / Inactive: 1
Platform Technologies
Viral vector: 1
Target Pathogens & Indications
Kidney Transplant Recipient
Vaccine Pipeline Candidates (1)
Detailed candidate profiles, clinical phases, target indications, and anticipated milestones.
Discontinued / Inactive
ctgov-janssen-ad26-cov2-s-vaccine-mark-stegall
Janssen Ad26.CoV2.S Vaccine
Target: Kidney Transplant Recipient
Platform: Viral vector
Key Milestone: Primary completion (most advanced trial): 2025-02-28 (registry estimate)
Explore Other Vaccine Developers & Sponsors
Compare pipeline volume, phase progression, and modalities across global biopharmaceutical manufacturers.